Pharm-Olam Croatia

Pharm-Olam has conducted clinical trials in Croatia since 2006 and we have an office in the capital city of Zagreb. Croatia is currently an EU candidate country with schedule ascension in July 2013.

Pharm-Olam offers comprehensive services and functional outsourcing for Phase I to IV clinical research studies in Croatia, including monitoring, regulatory, pharmacovigilance (including EudraVigilance), data management, project management, and biostatistics.

For more information on conducting clinical trials with Pharm-Olam in Croatia, please Contact Us.

Office Location: Zagreb

Croatia Demographics

Population: 4.5 million (57% urbanized)
Median Age: 41 years
Language: Croatian

Regulatory Authorities

HALMED (in English)
Ministry of Health (in Croatian)

Clinical Trials in Croatia

clinicaltrials.gov Active Studies

Argentina (Buenos Aires), Belarus (Minsk), Belgium (Brussels), Brazil (São Paulo), Bulgaria (Sofia), Canada (Toronto), Croatia (Zagreb), Czech Rep. (Prague), Georgia (Tbilisi), Germany (Munich), Hungary (Budapest), India (Bangalore), Italy (Milan), Kazakhstan (Almaty), Mexico (Mexico City), Poland (Warsaw), Romania (Bucharest), Russia (Moscow, St. Petersburg, Novosibirsk), Serbia (Belgrade), Spain (Madrid), South Africa (Johannesburg), Ukraine (Kiev), United Kingdom (London), United States (Houston, Princeton, Research Triangle Park)